GEAR is a cutting-edge WebAssembly smart contract platform based on Substrate
GEAR is a cutting-edge WebAssembly smart contract platform based on Substrate. We ensure a seamless transition from the world of Web 2.0 development to the realm of Web 3.0 by providing tools to build and deploy decentralized applications on blockchain in a matter of minutes.
GEAR is a cutting-edge WebAssembly smart contract platform based on Substrate. We ensure a seamless transition from the world of Web 2.0 development to the realm of Web 3.
0 by providing tools to build and deploy decentralized applications on blockchain in a matter of minutes.
InfrastructureBlockchainGauntlet’s mission is to drive understanding and participation in the financial systems of the future. Building decentralized systems creates new challenges for protocol developers, smart contract developers, and asset holders that are not seen in traditional development and investing. Gauntlet ha
InfrastructureBlockchainGBI is a rapidly growing fintech company, building groundbreaking technology at the intersection of alternative assets, including cryptocurrencies and precious.
InfrastructureArtificial IntelligenceGBR Technologies (Grabox) is a thriving hospitality business that aims to create new and engaging consumer experiences. We help food brands and businesses target and connect with their customers and audiences at a hyperlocal level, thus boosting their reach and variety of offerings. Over 3+ years of
InfrastructureBlockchainGem is a cryptocurrency API company that powers fiat-to-crypto onramps for some of the largest companies in the cryptocurrency industry. Gem gives our partners a beautiful user interface to the crypto universe with just a few lines of code. Our flagship product, Gem Onramp is the "Add Money" button
InfrastructureArtificial IntelligenceGenesis Molecular AI – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego and offices in New York – is pioneering foundation models for molecular AI to unlock a new era of drug design and development. We are using a proprietary state-of-the-art generative and predictive
InfrastructureArtificial IntelligenceGenesis Therapeutics is unifying AI and biotech to accelerate and optimize drug discovery. We pioneer novel deep learning and molecular simulation techniques to accelerate the development of new medicines. Genesis raised its $52M Series A from top tech + biotech investors, Andreessen Horowitz, Roc